FDA Approved: VYALEV — Supplemental Application (AbbVie Inc.)

View source ↗

Summary

FDA approved a supplemental application for VYALEV (foscarbidopa/foslevodopa) from AbbVie.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• VYALEV (foscarbidopa/foslevodopa)

Snippet

SUPPL AP for VYALEV (FOSCARBIDOPA/FOSLEVODOPA)